• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COBAS INTEGRA CREATININE PLUS VER.2 ASSAY; ENZYMATIC METHOD, CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COBAS INTEGRA CREATININE PLUS VER.2 ASSAY; ENZYMATIC METHOD, CREATININE Back to Search Results
Catalog Number 03263991190
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/01/2024
Event Type  malfunction  
Manufacturer Narrative
The cobas 8000 cobas c 502 module serial number was (b)(6).The investigation is ongoing.
 
Event Description
There was an allegation of questionable creatinine (crep gen.2) results from the cobas 8000 cobas c 502 module.The patient was a transplant patient and was regularly checked by his nephrologist who claimed the results were too high and did not fit the patient history and status.The customer questioned if there was an interference with the patient's medications.The creatinine result using the jaffe method in another laboratory was <100 ¿mol/l.The creatinine results using the enzymatic method were 223 ¿mol/l and 177 umol/l.The results were obtained with different samples from different venipunctures.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS INTEGRA CREATININE PLUS VER.2 ASSAY
Type of Device
ENZYMATIC METHOD, CREATININE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key18978772
MDR Text Key338600141
Report Number1823260-2024-00904
Device Sequence Number1
Product Code JFY
UDI-Device Identifier04015630919215
UDI-Public04015630919215
Combination Product (y/n)Y
Reporter Country CodeGM
PMA/PMN Number
K024098
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/26/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number03263991190
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/07/2024
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ATENOLO; CANDESARTAN; CELLCEPT/MYFORTIC; COTRIM; COTRIMOXAZOLE; CYCLOSPORIN A; DEKRISTOL; MYCOPHENOLATE; PANTOZOL; PREDNISOLON; TESTIM
-
-